Small Caps
Consulier Engineering (CSLR) was sharply higher and was the Nasdaq's leading percentage gainer, shattering its old 52-week high in the process. Recently, the stock was soaring $5.78, or 173%, to $9.12. Volume was heavier than normal. However, no news was evident. Shares of Consulier went as high as $14.88 earlier in the session. The previous high during the past year was $5.99.
Commonwealth Biotechnologies (CBTE) was surging a day after it agreed to acquire Australia's Mimotopes. Mimotopes is focused on the market for research-grade peptides and peptide therapeutics. Shares of Commonwealth were up 52% to $3.20. Anika Therapeutics (ANIK) advanced 24.6% to $14.40 following word that it received an approvable letter from the Food and Drug Administration for its cosmetic tissue augmentation product. CTA is an injectable soft-tissue filler for facial wrinkles, scar remediation and lip augmentation. The final approval is expected by the end of the year. Patient Safety Technologies (PST) slumped after saying it didn't file its quarterly 10-Q within the five-day extension period. The company now expects to file its Sept. 30 10-Q within the next one to two weeks. Additionally, the company received notice from the American Stock Exchange that it isn't in compliance with certain continued listing standards. Shares of Patient Safety were losing 21% to $1.47. US LEC (CLEC) said Tansukh Ganatra, the company's co-founder, past CEO and a member of the board, has been named interim CEO to replace Aaron Cowell, who will step down Dec. 4. Cowell's departure was expected with an anticipated year-end closing of the US LEC and Paetec Communications merger. The merger is now expected to close in the first quarter. Shares of US LEC were down 1.9% to $8.33.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |


Connect with TheStreet